Bibliotheek

Wilt u meer te weten komen over het klinische voordeel van kankerbiomerkers? De laatste publicaties van onze laureaten lezen? Of beter begrijpen hoe ons filantropisch venture-model tijd en levens kan redden? 

Hier vindt u een selectie uit onze bronnen.

New findings to guide the development of prognostic, diagnostic and therapeutic strategies

Gepost op 17-10-2013
Analysis of cancer genomes is moving beyond the confines of a particular disease - researchers are now comparing the genetic and epigenetic characteristics of multiple tumors types. Their findings provide not only biology insight, but also clinically relevant information. Discover how by following the link below.

Honest Brokers for Cure

Gepost op 13-09-2013
How Venture Philantropy Groups are changing biomedical research

Why Your New Cancer Biomarker May Never Work ?

Gepost op 13-09-2013
Recurrent Patterns and Remarkable Diversity in Biomarker Failures

The Biomarker Unbound

Gepost op 13-09-2013
The Supreme Court's Ruling on Diagnostic - Test Patents

Evolution of Translational Omics

Gepost op 13-09-2013
Lessons learned and the Path forward